• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病合并口腔恶性外周神经鞘膜瘤1例报告

A case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1.

作者信息

Oztürk Ozmen, Tutkun Alper

机构信息

Department of Otorhinolaryngology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey ; Kulak Burun Bogaz Anabilim Dalı, Istanbul Medipol Universitesi, Kosuyolu, Kadikoy, 34718 Istanbul, Turkey.

出版信息

Case Rep Otolaryngol. 2012;2012:936735. doi: 10.1155/2012/936735. Epub 2012 Nov 6.

DOI:10.1155/2012/936735
PMID:23198228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3502806/
Abstract

Patients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in about 2% to 5% of neurofibromatosis patients. In this paper, we present a 16-year-old male patient with neurofibromatosis who developed MPNST of the retromolar area. The mass enlarged rapidly in a period of 6 weeks. The patient was treated surgically, and a tumor mass with a diameter of 7 × 6 × 4 cm was excised, but after 8 months a recurrence was observed at the same site. The sarcomatous change in a neurofibroma has an extremely poor prognosis, so patients with neurofibromatosis should be closely monitored for a possible malignancy. A rapid change in size of a preexisting neurofibroma, infiltration of the adjacent structures, intralesional hemorrhage, and pain indicate a possible malignant transformation to MPNST.

摘要

1型神经纤维瘤病患者发生良性和恶性肿瘤的频率增加。大多数恶性外周神经鞘瘤(MPNST)被认为是起源于间充质组织的高级别肉瘤。一般认为,MPNST发生在约2%至5%的神经纤维瘤病患者中。在本文中,我们报告了一名16岁患有神经纤维瘤病的男性患者,其发生了磨牙后区的MPNST。肿块在6周内迅速增大。患者接受了手术治疗,切除了一个直径为7×6×4 cm的肿瘤肿块,但8个月后在同一部位观察到复发。神经纤维瘤的肉瘤样变预后极差,因此神经纤维瘤病患者应密切监测是否可能发生恶变。既往存在的神经纤维瘤大小迅速改变、邻近结构浸润、瘤内出血和疼痛提示可能恶变转化为MPNST。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/3c9e26e71bf8/CRIM.OTOLARYNGOLOGY2012-936735.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/eba44379d140/CRIM.OTOLARYNGOLOGY2012-936735.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/d3b722d610fd/CRIM.OTOLARYNGOLOGY2012-936735.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/5359a9f38984/CRIM.OTOLARYNGOLOGY2012-936735.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/3c9e26e71bf8/CRIM.OTOLARYNGOLOGY2012-936735.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/eba44379d140/CRIM.OTOLARYNGOLOGY2012-936735.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/d3b722d610fd/CRIM.OTOLARYNGOLOGY2012-936735.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/5359a9f38984/CRIM.OTOLARYNGOLOGY2012-936735.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8f/3502806/3c9e26e71bf8/CRIM.OTOLARYNGOLOGY2012-936735.004.jpg

相似文献

1
A case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1.1型神经纤维瘤病合并口腔恶性外周神经鞘膜瘤1例报告
Case Rep Otolaryngol. 2012;2012:936735. doi: 10.1155/2012/936735. Epub 2012 Nov 6.
2
Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.18 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在鉴别 1 型神经纤维瘤病相关的良性神经纤维瘤与恶性外周神经鞘瘤中的作用。
Neurosurgery. 2009 Oct;65(4 Suppl):A160-70. doi: 10.1227/01.NEU.0000337597.18599.D3.
3
Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.1型神经纤维瘤病中周围神经鞘肿瘤的病理学
Am J Med Genet. 1999 Mar 26;89(1):23-30. doi: 10.1002/(sici)1096-8628(19990326)89:1<23::aid-ajmg6>3.0.co;2-#.
4
Malignant Peripheral Nerve Sheath Tumor.恶性外周神经鞘膜瘤
Surg Oncol Clin N Am. 2016 Oct;25(4):789-802. doi: 10.1016/j.soc.2016.05.009.
5
High-Grade Malignant Peripheral Nerve Sheath Tumor Arising From Common Peroneal Nerve Neurofibroma.源于腓总神经神经纤维瘤的高级别恶性外周神经鞘瘤。
Cureus. 2024 May 3;16(5):e59607. doi: 10.7759/cureus.59607. eCollection 2024 May.
6
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.散发型、神经纤维瘤病 1 型相关和放射相关恶性外周神经鞘瘤的复发和生存模式。
J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1.
7
Plexiform neurofibromatosis with peripheral malignant nerve sheath tumor and scoliosis - more surveillance imaging needed?伴有周围性恶性神经鞘瘤和脊柱侧弯的丛状神经纤维瘤病——是否需要更多的监测影像学检查?
Radiol Case Rep. 2022 May 6;17(7):2388-2393. doi: 10.1016/j.radcr.2022.03.111. eCollection 2022 Jul.
8
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.恶性外周神经鞘瘤:神经纤维瘤病 2 型患者的恶变。
Pediatr Blood Cancer. 2019 Feb;66(2):e27520. doi: 10.1002/pbc.27520. Epub 2018 Nov 8.
9
Giant malignant peripheral nerve sheath tumor of thigh in an adolescent with neurofibromatosis type 1: a case report.1型神经纤维瘤病青少年患者的大腿巨大恶性外周神经鞘瘤:一例报告
Int Med Case Rep J. 2015 Oct 28;8:267-71. doi: 10.2147/IMCRJ.S92015. eCollection 2015.
10
A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.一例神经源性肿瘤,包含一个伴有p16表达缺失及CDKN2A/p16纯合性缺失的低级别恶性外周神经鞘膜瘤(MPNST)成分:一例显示从神经纤维瘤进展为高级别MPNST的病例报告。
Int J Clin Exp Pathol. 2015 May 1;8(5):5113-20. eCollection 2015.

引用本文的文献

1
Facial Diffuse Plexiform Neurofibroma-associated Mandibular Deformities: Surgical Interventions and Monitoring of Treatment Results in a Patient for Over 40 Years.面部弥漫性丛状神经纤维瘤相关的下颌骨畸形:一名患者40多年的手术干预及治疗结果监测
Cancer Diagn Progn. 2025 May 3;5(3):319-329. doi: 10.21873/cdp.10444. eCollection 2025 May-Jun.
2
Malignant peripheral nerve sheath tumour presenting as pathological fracture of proximal femur in neurofibromatosis type-1: a case report with brief literature search.1型神经纤维瘤病中表现为股骨近端病理性骨折的恶性周围神经鞘瘤:一例报告并简要文献检索
Int J Burns Trauma. 2024 Aug 25;14(4):90-95. doi: 10.62347/IGKP3358. eCollection 2024.
3

本文引用的文献

1
Malignant nerve sheath tumor of the spinal accessory nerve: a unique presentation of a rare tumor.副神经恶性神经鞘瘤:一种罕见肿瘤的独特表现。
J Clin Neurol. 2012 Mar;8(1):75-8. doi: 10.3988/jcn.2012.8.1.75. Epub 2012 Mar 31.
2
Malignant peripheral nerve sheath tumors.恶性外周神经鞘瘤
Neurosurg Clin N Am. 2008 Oct;19(4):533-43, v. doi: 10.1016/j.nec.2008.07.004.
3
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.关于神经纤维瘤病中恶性外周神经鞘膜瘤的国际共识声明。
Malignant peripheral nerve sheath tumor of tongue: a case report.
舌部恶性外周神经鞘瘤 1 例报告
Hua Xi Kou Qiang Yi Xue Za Zhi. 2023 Jun 1;41(3):361-364. doi: 10.7518/hxkq.2023.2022402.
4
Malignant peripheral nerve sheath tumor (MPNST) arising from angiosarcoma: a rare case report.源于血管肉瘤的恶性外周神经鞘瘤:一例罕见病例报告
Oral Maxillofac Surg. 2019 Mar;23(1):109-112. doi: 10.1007/s10006-018-0740-8. Epub 2019 Jan 7.
5
Retroperitoneal Malignant Peripheral Nerve Sheath Tumour: A Rare Case Report.腹膜后恶性周围神经鞘瘤:1例罕见病例报告
J Clin Diagn Res. 2015 Sep;9(9):ED09-11. doi: 10.7860/JCDR/2015/14169.6481. Epub 2015 Sep 1.
6
Malignant peripheral nerve sheath tumor: A rarity.恶性外周神经鞘膜瘤:一种罕见病。
Indian J Dent. 2015 Jan-Mar;6(1):53-6. doi: 10.4103/0975-962X.151712.
7
Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review.头颈部恶性外周神经鞘瘤:病例系列报道及文献综述
Case Rep Otolaryngol. 2014;2014:368920. doi: 10.1155/2014/368920. Epub 2014 Dec 4.
Cancer Res. 2002 Mar 1;62(5):1573-7.
4
Jaw and skull changes in neurofibromatosis.
Oral Surg Oral Med Oral Pathol. 1988 Sep;66(3):391-6. doi: 10.1016/0030-4220(88)90252-6.
5
Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.神经纤维瘤病。会议声明。美国国立卫生研究院共识发展会议。
Arch Neurol. 1988 May;45(5):575-8.